|
ZFHX3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.400590E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.30269999998323E-06 |
| Normal-vs-Stage2 |
1.734570E-01 |
| Normal-vs-Stage3 |
1.225980E-01 |
| Normal-vs-Stage4 |
4.421800E-01 |
| Stage1-vs-Stage2 |
2.321600E-01 |
| Stage1-vs-Stage3 |
2.051800E-01 |
| Stage1-vs-Stage4 |
3.783600E-01 |
| Stage2-vs-Stage3 |
9.685400E-01 |
| Stage2-vs-Stage4 |
9.072800E-01 |
| Stage3-vs-Stage4 |
8.813200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.59940000000437E-05 |
| Normal-vs-AfricanAmerican |
3.99269999999952E-05 |
| Normal-vs-Asian |
2.490800E-01 |
| Caucasian-vs-AfricanAmerican |
4.774200E-01 |
| Caucasian-vs-Asian |
6.424400E-01 |
| AfricanAmerican-vs-Asian |
3.636600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.79600000005387E-06 |
| Normal-vs-Female |
4.904200E-01 |
| Male-vs-Female |
1.014060E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.370500E-04 |
| Normal-vs-Extreme_Weight |
3.57729999955758E-07 |
| Normal-vs-Obese |
6.264000E-02 |
| Normal-vs-Extreme_Obese |
1.64823999999619E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.947590E-01 |
| Normal_Weight-vs-Obese |
2.207400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.587400E-01 |
| Extreme_Weight-vs-Obese |
1.189940E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.693600E-01 |
| Obese-vs-Extreme_Obese |
7.081800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.530200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.585300E-04 |
| Normal-vs-Age(61-80Yrs) |
3.93189999999821E-05 |
| Normal-vs-Age(81-100Yrs) |
2.3066000000016E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.997610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.099800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.295800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.496400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.560000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.291900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.10879999965152E-07 |
| Normal-VS-Type2 PRCC |
2.21269999989282E-07 |
| Normal-VS-KIRP CIMP |
3.951600E-02 |
| Normal-VS-Unclassified PRCC |
3.847000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.481200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.279600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.919530E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.957700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.356470E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.503100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.85739999994483E-06 |
| Normal-vs-N1 |
4.651800E-01 |
| Normal-vs-N2 |
9.395400E-01 |
| N0-vs-N1 |
5.670000E-02 |
| N0-vs-N2 |
3.607400E-01 |
| N1-vs-N2 |
7.033200E-01 |
|
|
